GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Equity-to-Asset

Kimia Biosciences (BOM:530313) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kimia Biosciences's Total Stockholders Equity for the quarter that ended in . 20 was ₹0.00 Mil. Kimia Biosciences's Total Assets for the quarter that ended in . 20 was ₹0.00 Mil.

The historical rank and industry rank for Kimia Biosciences's Equity-to-Asset or its related term are showing as below:

BOM:530313's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

Kimia Biosciences Equity-to-Asset Historical Data

The historical data trend for Kimia Biosciences's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Equity-to-Asset Chart

Kimia Biosciences Annual Data
Trend
Equity-to-Asset

Kimia Biosciences Semi-Annual Data
Equity-to-Asset

Competitive Comparison of Kimia Biosciences's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kimia Biosciences's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Equity-to-Asset falls into.



Kimia Biosciences Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Kimia Biosciences's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Kimia Biosciences's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kimia Biosciences  (BOM:530313) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Kimia Biosciences Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines